Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacotherapy in benign prostatic hyperplasia

E C Tan1

  • 1Mount Elizabeth Medical Centre, Singapore.

Annals of the Academy of Medicine, Singapore
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of renin-angiotensin-aldosterone system genetic polymorphisms with maternal hypotension during spinal anaesthesia for caesarean delivery: a retrospective cohort study.

International journal of obstetric anesthesia·2020
Same author

Cockayne Syndrome due to a maternally-inherited whole gene deletion of ERCC8 and a paternally-inherited ERCC8 exon 4 deletion.

Gene·2015
Same author

Screening of antiviral activities in medicinal plants extracts against dengue virus using dengue NS2B-NS3 protease assay.

Tropical biomedicine·2014
Same author

Effect of OPRM variant on labor analgesia and post-cesarean delivery analgesia.

International journal of obstetric anesthesia·2010
Same author

The influence of ATP-binding cassette sub-family B member -1 (ABCB1) genetic polymorphisms on acute and chronic pain after intrathecal morphine for caesarean section: a prospective cohort study.

International journal of obstetric anesthesia·2010
Same author

Danger signals of Philippine haemorrhagic fever.

Bulletin of the World Health Organization·2010
Same journal

"Gazing into the crystal ball of mortality prediction in conservative kidney care": Correspondence.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Vascular stiffness and sepsis mortality: A promising signal in search of clinical relevance.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Transcatheter aortic valve implantation for severe aortic regurgitation with Trilogy system: Initial Southeast Asia experience.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Singapore expert consensus on optimising lipid-lowering strategies in acute coronary syndrome: A modified Delphi study.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Association of estimated pulse wave velocity with 28-day mortality in sepsis: A MIMIC-IV study.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Prognostic value of the monocyte-to-albumin ratio in nasopharyngeal carcinoma: A retrospective cohort study.

Annals of the Academy of Medicine, Singapore·2026
See all related articles

Medical therapy is increasingly important for benign prostatic hyperplasia (BPH) symptoms, offering safe and reversible treatments like alpha 1 blockers and 5 alpha-reductase inhibitors. These options are particularly beneficial for high-risk patients with moderate to severe BPH.

Area of Science:

  • Urology
  • Pharmacology
  • Internal Medicine

Background:

  • Benign prostatic hyperplasia (BPH) conventionally treated with transurethral resection.
  • Growing understanding of BPH pathophysiology and surgical morbidity drives interest in medical alternatives.
  • Medical therapy offers a less invasive approach for managing BPH symptoms.

Purpose of the Study:

  • To review the efficacy and safety of current medical therapies for BPH.
  • To highlight the expanding role of pharmacotherapy in BPH management.
  • To discuss future directions in medical treatment for BPH.

Main Methods:

  • Review of recent clinical trials on alpha 1 blockers and 5 alpha-reductase inhibitors.
  • Analysis of drug safety profiles and side effect reversibility.

Related Experiment Videos

  • Evaluation of pharmacotherapy's suitability for different patient risk groups.

    • Main Results:

    • Alpha 1 blockers and 5 alpha-reductase inhibitors demonstrate effectiveness in BPH treatment.
    • These medications are generally safe with reversible side effects.
    • Medical therapy is a viable option, especially for high-risk patients with moderate to severe BPH symptoms.

    Conclusions:

    • Pharmacotherapy is a crucial component in modern BPH management.
    • Current medical treatments offer a safe and effective alternative to invasive procedures.
    • Further research into novel alpha blockers and anti-androgens could enhance pharmacotherapy's appeal.